Waters will join several venture investors including, Floodgate Capital, First Round Capital, Underscore VC, Founder Collective, and Y Combinator, to invest in TetraScience’s $8-million series A round of financing.
TetraScience, a Boston, MA-based cloud technology company for life sciences R&D, announced on Oct. 31, 2019 it obtained a strategic investment from Waters, a specialty measurement company located in Milford, MA.
Waters will join several venture investors including, Floodgate Capital, First Round Capital, Underscore VC, Founder Collective, and Y Combinator, to invest in TetraScience’s $8-million series A round of financing, according to a press release. TetraScience will use the funding to develop its commercial team and its list of global customers and partners.
"We are honored by this vote of confidence from a renowned industry leader," said Siping (Spin) Wang, co-founder and CEO of TetraScience, in the press release. "Waters Corporation brings to the table [more than] 60 years of experience in high value analytical technologies, scientific expertise, and a global footprint. We look forward to working together to transform the future of R&D."
"We believe that dynamic, young companies like TetraScience have an enabling role to play in advancing the way the scientific community collects, shares, and analyzes R&D data," added Alan Millar, senior director of Corporate Development for Waters, in the press release. "Waters is excited to support TetraScience via this investment."
Source: TetraScience
Clinical Supply Planning in Europe - Balancing Cost, Flexibility and Time
December 19th 2024The packaging and distribution of clinical supplies is a fundamental piece to the overall success of a clinical trial, and advance preparation can help establish a more efficient supply chain. Selecting the best geographical location for those activities, however, depends on the clinical trial protocol, business decisions, and even the investigational medicinal product (IMP) being studied.